Why Moderna and BioNTech Stocks Slipped Today
_0.png?locale=de){kind=logo}
Shares of Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) were slipping 4.3% and 3%, respectively, as of 3:51 p.m. EDT on Wednesday. The declines came after physicians in a presentation before an advisory panel to the Centers for Disease Control and Prevention (CDC) stated that the companies' COVID-19 vaccines were likely linked to cases of heart inflammation in adolescents and young adults.
The CDC convened the Advisory Committee on Immunization Practices (ACIP) after reviewing initial data that showed higher-than-expected cases of heart inflammation after the second dose of messenger RNA (mRNA) vaccines. The numbers were especially notable in younger men.
Image source: Getty Images.
Source Fool.com
